Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2016

Accounting Policies [Abstract]

Summary of Expenses in Special Items

“Special items” included (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2016		2015		2016		2015
Biomet-related
Merger consideration compensation expense	$	—	$	164.1	$	—	$	164.1
Retention plans		—		73.0		—		73.0
Consulting and professional fees		43.3		62.4		79.4		86.6
Employee termination benefits		3.1		64.5		7.2		64.9
Dedicated project personnel		21.2		8.1		42.9		9.1
Relocated facilities		6.3		0.9		8.0		0.9
Contract terminations		15.2		15.9		25.3		15.9
Information technology integration		3.1		—		4.5		—
Intangible asset impairment		28.0		—		28.0		—
Other		0.4		1.7		4.4		1.9
Total Biomet-related		120.6		390.6		199.7		416.4
Other
Consulting and professional fees		8.8		39.6		15.7		79.3
Employee termination benefits		—		0.7		—		0.8
Dedicated project personnel		1.5		10.1		3.3		22.5
Impairment/loss on disposal of assets		1.1		—		1.1		2.3
Relocated facilities		—		—		0.2		0.5
Certain litigation matters		—		20.3		—		20.3
Contract terminations		1.0		—		1.0		—
Information technology integration		0.2		—		0.3		—
Contingent consideration adjustments		—		—		—		2.3
Accelerated software amortization		—		—		—		1.5
Other		4.7		7.9		5.3		10.1
Total Other		17.3		78.6		26.9		139.6
Special items	$	137.9	$	469.2	$	226.6	$	556.0

Summary of Liabilities Related to Integration Plans

The following table summarizes the liabilities related to these integration plans (in millions):

	Employee Termination Benefits			Contract Terminations			Total
Balance at December 31, 2015	$	46.8		$	56.0		$	102.8
Additions		7.2			25.3			32.5
Cash payments		(16.7	)		(41.5	)		(58.2	)
Foreign currency exchange rate changes		(0.4	)		—			(0.4	)
Balance at June 30, 2016	$	36.9		$	39.8		$	76.7

Schedule of Prior Period Adjustment

Revised Consolidated Statement of Earnings and Comprehensive Income

	Three Months Ended March 31, 2016
	As Reported		Adjustment			As Revised
Provision for income taxes	$	49.0	$	(2.9	)	$	46.1
Net earnings		105.8		2.9			108.7
Net Earnings of Zimmer Biomet Holdings, Inc.		105.9		2.9			108.8
Weighted Average Common Shares Outstanding—Diluted		202.0		0.2			202.2
Earnings Per Common Share—Basic	$	0.53	$	0.01		$	0.54
Earnings Per Common Share—Diluted		0.52		0.02			0.54
Comprehensive Income	$	191.9	$	2.9		$	194.8
Comprehensive Income attributable to Zimmer Biomet Holdings, Inc.		192.1		2.9			195.0

Revised Balance Sheet

	As of March 31, 2016
	As Reported		Adjustment			As Revised
Paid-in capital	$	8,233.5	$	(2.9	)	$	8,230.6
Retained earnings		8,407.5		2.9			8,410.4

Revised Statements of Cash Flows

	Three Months Ended March 31, 2016
	As Reported			Adjustment			As Revised
Net cash provided by operating activities	$	265.2		$	7.6		$	272.8
Net cash used in financing activities		(825.3	)		(7.6	)		(832.9	)

	Six Months Ended June 30, 2015
	As Reported		Adjustment			As Revised
Net cash provided by operating activities	$	278.3	$	10.4		$	288.7
Net cash provided by financing activities		7,799.7		(10.4	)		7,789.3